• Publications
  • Influence
Synthesis and Evaluation of New HCV NS3/4A Protease Inhibitors
The Hepatitis C virus infects an estimated 170 million people worldwide, and is the major cause of hepatitis, cirrhosis and liver cancer. The available treatment is a combination therapy with twoExpand
Synthesis and Evaluation of New HCV NS 3 / 4 A Protease Inhibitors
The Hepatitis C virus infects an estimated 170 million people worldwide, and is the major cause of hepatitis, cirrhosis and liver cancer. The available treatment is a combination therapy with twoExpand